Home

Publications

Publications

Publicly available publications related to the EUCLIDs project:


lchishol's picture

Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease.

 

Nat Genet. 2010 Sep;42(9):772-6

Meningococcal disease is an infection caused by Neisseria meningitidis. Genetic factors contribute to host susceptibility and progression to disease, but the genes responsible for disease development are largely unknown. We report here a genome-wide association study for host susceptibility to meningococcal disease using 475 individuals with meningococcal disease (cases) and 4,703 population controls from the UK. We performed, in Western European and South European cohorts (consisting of 968 cases and 1,376 controls), two replication studies for the most significant SNPs. A cluster of complement factor SNPs replicated independently in both cohorts, including SNPs within complement factor H (CFH) (rs1065489 (p.936D<E), P = 2.2 x 10(-11)) and in CFH-related protein 3 (CFHR3)(rs426736, P = 4.6 x 10(-13)). N. meningitidis is known to evade complement-mediated killing by the binding of host CFH to the meningococcal factor H-binding protein (fHbp). Our study suggests that host genetic variation in these regulators of complement activation plays a role in determining the occurrence of invasive disease versus asymptomatic colonization by this pathogen.  The work describe was not funded by EUCLIDS.

 

 

 

Publication Date: 
Wednesday, September 1, 2010 - 08:45
Authors: 
Davila S, Wright VJ, Khor CC, Sim KS, Binder A, Breunis WB, Inwald D, Nadel S, Betts H, Carrol ED, de Groot R, Hermans PW, Hazelzet J, Emonts M, Lim CC, Kuijpers TW, Martinon-Torres F, Salas A, Zenz W, Levin M, Hibberd ML; International Meningococcal Gene
Work Package: 
lchishol's picture

Characterizing vaccine responses using host genomic and transcriptomic analysis

Vaccines have had a profound influence on human health with no other health intervention rivalling theirimpact on themorbidity andmortality associated with infectious disease.However, the magnitude and persistence of vaccine immunity varies considerably between individuals, a phenomenon thatis not well understood. Recentstudies have used contemporary technologies to correlate variation in the genome and transcriptome to immunologicalmeasures of vaccine responsiveness. These approaches have provided fresh insightinto the intrinsic factors determining the potency and duration of vaccine‐induced immunity. The fundamental  challenge will be to translate these findingsinto innovative and pragmatic strategiesto develop new andmore effective vaccines.
 
 
 
Publication Date: 
Friday, May 31, 2013 - 16:00
Lead Author: 
DanielO’Connor
Authors: 
Andrew J. Pollard
Work Package: